Abstract:Background
Emergency department patients are disproportionately non-adherent with the United States Preventive Services Task Force cancer screening recommendations, making the emergency department a target-rich environment for interventions aimed at increasing the uptake of cancer screening. Promotion of cancer screening in the emergency department has the potential to address health disparities and to reach patients that experience significant barriers to accessing preventive care.
… Show more
“…Increasing evidence has demonstrated that the ED is in a unique position to address disparities in cancer prevention and screening. 7 As demonstrated in this work, ED patients are disproportionally non-adherent with the USPSTF cancer screening recommendations and, thus, the ED is a desirable location to reach these populations that otherwise would not have access to preventive services. 20 Examples of success in addressing cancer prevention/screening in the ED include a randomized controlled trial by Adler et al 21 Their study demonstrated the feasibility and efficacy of a behavioral intervention to increase uptake of cervical cancer screening among ED patients at an urban, academic ED.…”
Section: Discussionmentioning
confidence: 87%
“…It has been reported that ED patients are disproportionately non-adherent with the USPSTF cancer screening recommendations. 7 Disparities in cancer screening, including socioeconomic status (SES) and racial/ethnic status are pervasive in the literature, and has been further exacerbated by the coronavirus 2019 pandemic. 8 Despite the fact that EDs serve as a safety net for vulnerable populations who suffer from health disparities, limited work has explored the missed opportunities for cancer screening among ED patients.…”
Section: How Does This Improve Population Health?mentioning
confidence: 99%
“…It has been reported that ED patients are disproportionately non-adherent with the USPSTF cancer screening recommendations. 7 …”
Introduction: A suspected diagnosis of cancer through an emergency department (ED) visit is associated with poor clinical outcomes. The purpose of this study was to explore the rate at which ED patients attend cancer screenings for lung, colorectal (CRC), and breast cancers based on national guidelines set forth by the United States Preventive Services Task Force (USPSTF).
Methods: This was a prospective cohort study. Patients were randomly approached in the Eskenazi Hospital ED between August 2019–February 2020 and were surveyed to determine whether they would be eligible and had attended lung, CRC, and breast cancer screenings, as well as their awareness of lung cancer screening with low-dose computed tomography (LDCT). Patients who were English-speaking and ≥18 years old, and who were not critically ill or intoxicated or being seen for acute decompensated psychiatric illness were offered enrollment. Enrolled subjects were surveyed to determine eligibility for lung, colorectal, and breast cancer screenings based on guidelines set by the USPSTF. No cancer screenings were actually done during the ED visit.
Results: A total of 500 patients were enrolled in this study. More participants were female (54.4%), and a majority were Black (53.0%). Most participants had both insurance (80.2%) and access to primary care (62.8%). Among the entire cohort, 63.0% identified as smokers, and 62.2% (140/225) of the 50- to 80-year-old participants qualified for lung cancer screening. No patients were screened for lung cancer in this cohort (0/225). Only 0.6% (3/500) were aware that LDCT was the preferred method for screening. Based on pack years, 35.5% (32/90) of the patients who were 40-49 years old and 6.7% (6/90) of those 30–39 years old would eventually qualify for screening. Regarding CRC screening, 43.6% (218/500) of the entire cohort was eligible. However, of those patients only 54% (118/218) had been screened. Comparatively, 77.7% (87/112) of the eligible females had been screened for breast cancer, but only 54.5% (61/112) had been screened in the prior two years.
Conclusion: Many ED patients are not screened for lung/colorectal/breast cancers even though many are eligible and have reported access to primary care. This study demonstrates an opportunity and a need to address cancer screening in the ED.
“…Increasing evidence has demonstrated that the ED is in a unique position to address disparities in cancer prevention and screening. 7 As demonstrated in this work, ED patients are disproportionally non-adherent with the USPSTF cancer screening recommendations and, thus, the ED is a desirable location to reach these populations that otherwise would not have access to preventive services. 20 Examples of success in addressing cancer prevention/screening in the ED include a randomized controlled trial by Adler et al 21 Their study demonstrated the feasibility and efficacy of a behavioral intervention to increase uptake of cervical cancer screening among ED patients at an urban, academic ED.…”
Section: Discussionmentioning
confidence: 87%
“…It has been reported that ED patients are disproportionately non-adherent with the USPSTF cancer screening recommendations. 7 Disparities in cancer screening, including socioeconomic status (SES) and racial/ethnic status are pervasive in the literature, and has been further exacerbated by the coronavirus 2019 pandemic. 8 Despite the fact that EDs serve as a safety net for vulnerable populations who suffer from health disparities, limited work has explored the missed opportunities for cancer screening among ED patients.…”
Section: How Does This Improve Population Health?mentioning
confidence: 99%
“…It has been reported that ED patients are disproportionately non-adherent with the USPSTF cancer screening recommendations. 7 …”
Introduction: A suspected diagnosis of cancer through an emergency department (ED) visit is associated with poor clinical outcomes. The purpose of this study was to explore the rate at which ED patients attend cancer screenings for lung, colorectal (CRC), and breast cancers based on national guidelines set forth by the United States Preventive Services Task Force (USPSTF).
Methods: This was a prospective cohort study. Patients were randomly approached in the Eskenazi Hospital ED between August 2019–February 2020 and were surveyed to determine whether they would be eligible and had attended lung, CRC, and breast cancer screenings, as well as their awareness of lung cancer screening with low-dose computed tomography (LDCT). Patients who were English-speaking and ≥18 years old, and who were not critically ill or intoxicated or being seen for acute decompensated psychiatric illness were offered enrollment. Enrolled subjects were surveyed to determine eligibility for lung, colorectal, and breast cancer screenings based on guidelines set by the USPSTF. No cancer screenings were actually done during the ED visit.
Results: A total of 500 patients were enrolled in this study. More participants were female (54.4%), and a majority were Black (53.0%). Most participants had both insurance (80.2%) and access to primary care (62.8%). Among the entire cohort, 63.0% identified as smokers, and 62.2% (140/225) of the 50- to 80-year-old participants qualified for lung cancer screening. No patients were screened for lung cancer in this cohort (0/225). Only 0.6% (3/500) were aware that LDCT was the preferred method for screening. Based on pack years, 35.5% (32/90) of the patients who were 40-49 years old and 6.7% (6/90) of those 30–39 years old would eventually qualify for screening. Regarding CRC screening, 43.6% (218/500) of the entire cohort was eligible. However, of those patients only 54% (118/218) had been screened. Comparatively, 77.7% (87/112) of the eligible females had been screened for breast cancer, but only 54.5% (61/112) had been screened in the prior two years.
Conclusion: Many ED patients are not screened for lung/colorectal/breast cancers even though many are eligible and have reported access to primary care. This study demonstrates an opportunity and a need to address cancer screening in the ED.
“…Little to no literature exists examining the association with eventual cancer diagnosis in association with an ED visit, offering opportunities for addressing cancer prevention and cancer screening in the context of an ED visit. 19 …”
Introduction: Many patients receive a suspected diagnosis of cancer through an emergency department (ED) visit. Time to treatment for a new diagnosis of cancer is directly associated with improved outcomes with little no describing the ED utilization prior to the diagnosis of cancer. We hypothesize that patients that have an ED visit in proximity to a diagnosis of cancer will have worse outcomes, including mortality.Methods: This study is a retrospective cohort study of all patients with cancer diagnosed at Eskenazi Health (Indiana) between 2016 and 2019. Individual health characteristics, ED utilization, cancer types, and mortality were studied. We compared those patients seen in the ED within 6 months prior to their diagnosis (cases) to patients not seen in the ED (controls).Results: A total of 3699 patients with cancer were included, with 1239 cases (33.50%). Patients of black race had higher frequencies in the cases vs. controls (46.57% vs. 40.68%). Lung cancer was the most frequently observed cancer among cases vs. controls (11.70% vs. 5.57%). For the cases, 232 patients were deceased (18.72%) compared with 247 patients among the controls (10.04%, p < 0.0001, OR 2.06 95% confidence interval [CI] 1. 70-2.51). An ED visit in past 6 months (OR = 1.73, 95% CI 1.38-2.18) and Medicaid insurance type (versus commercial, OR = 4.16, 95% CI 2.45-7.07) were associated with of mortality. Female gender (OR = 0.76, 95% CI 0.67-0.88), tobacco use (OR = 1.62, 95% CI 138-1.90), and Medicaid insurance type (versus commercial, OR = 2.56, 95% CI 2.07-3.47) were associated with prior ED use.
Conclusions:Over one third of patients with cancer were seen in the ED within 6 months prior to their cancer diagnosis. Higher mortality rates were observed for those seen in the ED. Future studies are needed to investigate the association and impact that the ED has on eventual cancer diagnoses and outcomes.
“…Previous work has shown that the ED sees a high volume of patients who are not up-to-date with USPSTF cancer screening recommendations. For example, previous cross-sectional [ 12 ] and experimental work [ 13 ] using research associates to interview patients has demonstrated that a substantial proportion of women in the ED are not adherent with cervical and/or breast cancer guidelines (for a thorough review of ED-based cancer screening research, see Adler, Abar, and Chiao [ 14 ]). To date, however, limited work has been dedicated to developing scalable and sustainable methods for identifying ED patients in need of colorectal cancer screening.…”
Background
Despite unanimous recommendations from numerous specialty societies on regular colorectal cancer screening, a substantial proportion of eligible adults are non-adherent with screening. The current study investigated whether research associates (RAs) in the emergency department (ED) can adequately assess patients’ adherence with colorectal cancer screening recommendations, outlined by the US Preventive Services Task Force (USPSTF), and provide referrals to individuals who are found to be non-adherent.
Methods
RAs at seven heterogeneous hospitals in the USA queried non-emergent adult patients and visitors between the ages of 50 and 75. After obtaining verbal consent, the participant’s adherence with USPSTF guidelines for colorectal cancer screening was assessed. Participants found due for screening were provided with referrals to obtain these recommended screenings.
Results
A total of 8258 participants were surveyed on their colorectal cancer screening status, with RAs identifying 2063 participants who were not adherent with USPSTF guidelines for colorectal cancer screening and 67 for whom adherence could not be determined (total 27%).
Conclusions
Our study demonstrates that RAs can identify a large volume of eligible adults who would benefit from colorectal cancer screening across a variety of emergency department settings.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.